Skip to the page

Data / Drug companies / PT. Eagle Indo Pharma

PT. Eagle Indo Pharma: 20 products in the FDA NDC directory, labeler code 60954

PT. Eagle Indo Pharma (labeler code 60954) lists 20 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 20 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
60954
Products in commercial distribution
20
Packages
38
Finished drugs by generic name
7
Prescription products
0
Over the counter products
20
Flagged as original packager
18 of 18 products that carry the flag
Started marketing in the last 12 months
4
Earliest marketing start
May 14, 2010
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs20100%

Products by type

TypeProductsShare
Over the counter drugs20100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Oil1260%
Ointment630%
Cream15%
Liquid15%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Eagle Brand Massage Balm60954-202OintmentOver the counter monograph drugsNovember 3, 2026
Eagle Brand Medicated Roll On60954-020OilOver the counter monograph drugsApril 1, 2026
Eagle Brand Muscle Rub60954-019LiquidOver the counter monograph drugsApril 1, 2026
Eagle Brand Medicated Oil60954-018OilOver the counter monograph drugsApril 1, 2026
Eagle Brand Medicated Roll On60954-016OilOver the counter monograph drugsJune 24, 2024
Eagle Brand Medicated Oil60954-015OilOver the counter monograph drugsJune 24, 2024
Eagle Brand Eagle Balm60954-201OintmentOver the counter monograph drugsDecember 4, 2023
Eagle Brand Medicated Oil Refresh60954-013OilOver the counter monograph drugsNovember 2, 2023
Eagle Brand Medicated Roll On Aromatic60954-017OilOver the counter monograph drugsNovember 1, 2023
Eagle Brand Medicated Oil Aromatic60954-014OilOver the counter monograph drugsNovember 1, 2023
Eagle Brand Medicated Roll On Refresh60954-012OilOver the counter monograph drugsNovember 1, 2023
Geliga Muscular Balm60954-003OintmentOver the counter monograph drugsJuly 3, 2023
Geliga Muscular60954-004CreamOver the counter monograph drugsMay 8, 2023
Eagle Medicated Aromatic60954-007OilOver the counter monograph drugsJune 20, 2022
Eagle Medicated Oil Refreshing60954-005OilOver the counter monograph drugsJune 20, 2022
Eagle Medicated60954-002OilOver the counter monograph drugsMarch 4, 2022
Eagle Balm60954-010OintmentOver the counter monograph drugsApril 15, 2019
Eagle Brand Muscular Balm60954-200OintmentOver the counter monograph drugsMay 14, 2015
Eagle Medicated60954-008OilOver the counter monograph drugsJune 20, 2012
Muscular Balm60954-001OintmentOver the counter monograph drugsMay 14, 2010

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.